618109-05-0 (伏立康唑N-氧化物,Voriconazole N-Oxide)

伏立康唑N-氧化物;(2R,3S)-2-(2,4-二氟苯基)-3-(5-氟-1-氧代-4-嘧啶基)-1-(1H-1,2,4-三唑-1-基)-2-丁醇;伏立康唑-N-氧化物;伏立康唑N-氧化物标准品;

Voriconazole N-Oxide;(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-1-oxidopyrimidin-1-ium-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol;A-(1H-1,2,4-triazol-1-ylmethyl)-1-oxide-4-pyrimidineethanol;A-(2,4-Difluorophenyl)-5-fluoro-;A-methyl-;AR,;CHEBI:175687;4-((2S,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)-5-fluoropyrimidine 1-oxide;UNII-684933R4SK;AKOS025394780;4-[(2S,3R)-3-(2,4-Difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-5-fluoropyrimidin-1-ium-1-olate;SCHEMBL15879291;UK-121265;UK 121265;DTXSID90434719;UK-121,265;(2R,3s)-2-(2,4-difluorophenyl)-3-(5-fluoro-1-oxido-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol;HY-137989;DB-222751;4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, 1-oxide, (alphaR,betaS)-;Q27264211;4-PYRIMIDINEETHANOL, .ALPHA.-(2,4-DIFLUOROPHENYL)-5-FLUORO-.BETA.-METHYL-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-, 1-OXIDE, (.ALPHA.R,.BETA.S)-;684933R4SK;(2R,3S)-2-(2,4-diluorophenyl)-3-(5-luoro-1-oxidopyrimidin-1-ium-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol;(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1-oxide-4-pyrimidineethanol;618109-05-0;4-Pyrimidineethanol, ?-(2,4-difluorophenyl)-5-fluoro-?-methyl-?-(1H-1,2,4-triazol-1-ylmethyl)-, 1-oxide, (?R,?S)-; UK 121265; Voriconazole N-oxide;CS-0143533;UK 121,265;UK121,265;DTXCID40385545;UK121265;4-Pyrimidineethanol, a-(2,4-difluorophenyl)-5-fluoro-ss-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-, 1-oxide, (aR,ssS)-; UK 121265; Voriconazole N-oxide;

KPLFPLUCFPRUHU-MGPLVRAMSA-N

1S/C16H14F3N5O2/c1-10(15-14(19)5-24(26)9-21-15)16(25,6-23-8-20-7-22-23)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1

FC1C=C(C=CC=1[C@@](CN1C=NC=N1)([C@H](C1C(=C[N+](=CN=1)[O-])F)C)O)F